Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
BMJ Open|April 20, 2024
Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT projectShelley Potter, Kerry Avery, Rosina Ahmed, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2013
Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcomeMila Donker, Marieke E Straver, Geertjan van Tienhoven, et al.
Clinical Breast Cancer|December 9, 2015
A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)Henry L Gómez, Silvia Neciosup, Célia Tosello, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 23, 2025
The GOG Foundation and EVA/LACOG partnership: a collaborative strategic alliance for clinical trial executionFernando Maluf, Robert L Coleman, Angélica Nogueira-Rodrigues, et al.
Ecancermedicalscience|August 3, 2023
Clinical validation and diagnostic accuracy of 99mTc-EDDA/HYNIC-TOC compared to 111In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 studyCristina M Moriguchi-Jeckel, Rafael R Madke, Graciane Radaelli, et al.
Therapeutic Advances in Medical Oncology|October 6, 2025
Factors associated with accepting chemotherapy despite the risk of fertility loss in Latin American breast cancer patients-LACOG 0414 studyGustavo Werutsky, Cynthia Villarreal-Garza, Henry L Gomez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2026
Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline UpdateZeina Nahleh, Catherine M Alfano, Mark R Somerfield, et al.
JTO Clinical and Research Reports|October 4, 2022
Assessing Oncologists' Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in BrazilAline F Fares, Pedro H Martinez, Pedro H Farina, et al.
Frontiers in Pharmacology|September 11, 2023
An international comparative analysis and roadmap to sustainable biosimilar marketsKhalid A Alnaqbi, Agnès Bellanger, Alex Brill, et al.
Ecancermedicalscience|May 22, 2024
Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, São Paulo, 2023Heloisa Resende, Roberto J Arai, Carlos H Barrios, et al.
Pageof 9